Asthma
Not recruitingLong-term safety study of dexpramipexole tablets in patients with severe eosinophilic asthma who completed EXHALE-2 or EXHALE-3 trials
Long-term safety study of dexpramipexole tablets in patients with severe eosinophilic asthma who completed EXHALE-2 or EXHALE-3 trials
- Disease:Asthma
- Substances:Dexpramipexole Dihydrochloride Monohydrate
Bulgaria- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Dexpramipexole Dihydrochloride Monohydrate
- Sponsor:Areteia Therapeutics Inc.













